← FDA Drug Approvals (Drugs@FDA)
LENALIDOMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2023-03-06
Drug application
- FDA Application #
ANDA214618- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LENALIDOMIDE
- Generic name
- LENALIDOMIDE
- Active ingredients
- LENALIDOMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CIPLA
- Manufacturer
- EXELAN PHARMACEUTICALS INC.
- First approval
- 2023-03-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown